Increasing Prevalence Of Chronic Diseases To Drive Market Growth: A Key Driver Powering Stem Cell Therapy Market Growth In 2025

The Stem Cell Therapy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Stem Cell Therapy Market Size and Its Estimated Growth Rate?
In the last few years, the stem cell therapy market has seen significant expansion. It is projected to experience growth from $7.86 billion in 2024 to a substantial $9.26 billion in 2025, with a compound annual growth rate (CAGR) of 17.7%. Factors contributing to the historic growth include heightened incidences of chronic illness, greater investment from government bodies and private entities, swift development in emerging markets, increased funding in cell and gene therapies, surge in healthcare spending, and a rise in research and development expenditure in the pharmaceutical sector.

Expectations for the stem cell therapy market size project a swift expansion in the coming years, reaching a value of $14.6 billion in 2029 at a compound annual growth rate of 12.1%. This anticipated growth throughout the forecast period is linked to increased governmental support, a fast growing elderly population, a rise in investment within research and development, and expanding healthcare expenditures. Over the course of this same period, notable trends point to a need for more strategic scrutiny of improvements in mesenchymal stem cell therapies, enabling capitalization on innovation within this area. Additionally, it is suggested that players within the market collaborate with other firms for acquisitions, to stimulate product innovation and revenue growth. Market entities should also contemplate investing in the creation of ipsc-derived nk cells for patient treatment, and prioritize developing stem cell treatments, especially cancer therapies, in order to gain an upper hand over somatic cell competitors. Moreover, businesses within the stem cell therapy sector should leverage artificial intelligence to enhance the quality, safety, and production efficiency of their products.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3399

How Are Emerging Segments Shaping the Stem Cell Therapy Market Landscape?
The stem cell therapy market covered in this report is segmented -

1) By Type: Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy
2) By Cell Source: Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells
3) By Application: Musculoskeletal Disorders and Wounds & Injuries, Cancer, Autoimmune Disorders, Others
4) By End-Users: Hospitals And Clinics, Research Centers, Others.

Subsegments:
1) By Allogeneic Stem Cell Therapy: Derived From Donors (Related Or Unrelated), Used For Various Conditions, Including Blood Disorders And Certain Cancers, Examples Include Umbilical Cord Blood Stem Cells And Peripheral Blood Stem Cells
2) By Autologous Stem Cell Therapy: Derived From The Patient's Own Cells, Used For Conditions Such As Orthopedic Injuries, Cardiac Diseases, And Certain Cancers, Involves The Harvesting Of Stem Cells From Tissues Like Bone Marrow Or Adipose Tissue

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3399&type=smp

Which Growth Factors Are Influencing Stem Cell Therapy Market Expansion?
The growth of the stem cell therapy market is being fueled by the increasing occurrence of chronic illnesses. Lifestyle factors such as extended working hours, lack of physical exercise, and poor dietary habits lead to a higher prevalence of these diseases, necessitating the use of stem cell therapy. A piece from the United Nations predicts that by 2030, chronic diseases will account for 70% of all deaths worldwide. The global impact of these diseases is anticipated to be around 60%. The growth of the stem cell therapy market is projected to escalate due to this increased occurrence of chronic diseases.

Who Are the Dominant Players Across Different Stem Cell Therapy Market Segments?
Major companies operating in the stem cell therapy market include Fujifilm Holding Corporation, Thermo Fisher Scientific Inc., Takara Bio Inc., MEDIPOST Co., Ltd., Astellas Pharma Inc., Catalent, Inc., Pharmicell Co., Ltd., JCR Pharmaceuticals Co., Ltd., Stemedica Cell Technologies, Inc., Pluristem Technologies Ltd, Becton Dickinson Private Limited, Stem Cell Technologies India Pvt. Ltd, Cordlife India Pvt. Ltd, Lifecell International Pvt. Ltd, Stemcyte India Therapeutics Private Limited, Stempeutics Research Private Limited, Anterogen Co., Ltd, Tonghua Dongbao Pharmaceutical Co, China Biologic Products Holdings Inc, Astrazenaca, Ablbio, Henlius, China Regenerative Medicine International, Innovent Biologics, Bio-Thera, Hisun Pharma, 3sbio, Beijing Shuanglu Pharmaceuticals, Qilu Pharmaceutical, Shanghai Fosun Pharmaceuticals, Cellerix, Cellgenix, Nsgene, Tigenix, Renuron Group, Smart Cells And Genenta Science, Amsterdam Molecular Therapeutics (Amt), Ark Therapeutics, Arthrogen Bv, Diamyd Medical Ab, Oxford Biomedica, Transgene, Mabion, Pure Biologics, Oncoarendi Therapeutics, Celon Pharma, Becton Dickinson And Company, Osiris Therapeutics, Capricortherapeutics, Cellular Dynamics Discgenics, Takeda Pharmaceuticals, Kolon Tissue Gene, Athersys, Cyro-Cell International, Geron Corporation, Mesoblast Ltd, Astrom Biosciences Inc, Invitrogen, Cytori Therapeutics Inc, Nuvasive Inc, Bristol-Myers Squibb Aldagen Inc, Caladrius Biosciences Inc, Biogen Sa, Daiichi Sankyo Co. Ltd, Gamida Cell Ltd, Gilead Sciences, Inc., Novartis Ag, Pfizer, Sanofi S.A.

What Are the Latest Developing Trends in the Stem Cell Therapy Market?
Strategic partnerships are increasingly becoming a common investment strategy among companies within the stem cell therapy market. This type of arrangement offers mutual benefits to the partnering companies that are not in direct competition with each other. To illustrate, SQZ Biotechnologies, an American biotechnology firm, formed a strategic partnership with STEMCELL Technologies Inc., originating from Canada, in May 2022. Their collective effort is aimed at the development and commercialization of a research-only microfluidic intracellular delivery system. This system, which leverages SQZ's Cell Squeeze technology, promises to enhance cell engineering capabilities for preclinical studies in the life sciences sector. Both companies anticipate revealing significant findings on the effective delivery of cargoes to primary immune cell types and advancements in cell engineering with mRNA and CRISPR/Cas9 in hematopoietic stem cells through the RUO system.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Which Geographic Regions Are Expected to Dominate the Stem Cell Therapy Market in the Coming Years?
North America was the largest region in the stem cell therapy market in 2024. The Middle East is expected to be the fastest-growing region in the global stem cell therapy market during the forecast period. The regions covered in the stem cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Stem Cell Therapy Market?
2. What is the CAGR expected in the Stem Cell Therapy Market?
3. What Are the Key Innovations Transforming the Stem Cell Therapy Industry?
4. Which Region Is Leading the Stem Cell Therapy Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.